Vanguard Portfolio Management
INDV icon

Vanguard Portfolio Management’s Indivior Pharmaceuticals INDV Stock Holding History

Vanguard Portfolio Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311M Sell
7,572,287
-319,532
-4% -$11.6M 0.01% 962
2026
Q1 		$241M Buy
+7,891,819
New +$261M 0.01% 1027

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Vanguard Portfolio Management's INDV Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its Indivior Pharmaceuticals (INDV) stake by 4% in Q2 2026, selling an estimated $11.6M and leaving 7,572,287 shares worth $311M. The position accounts for 0.01% of the portfolio, ranked #962.

Vanguard Portfolio Management first reported a position in INDV in Q1 2026 and has held it in 2 quarters since. 315 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Vanguard Portfolio Management held 7,572,287 shares of Indivior Pharmaceuticals worth $311M as of Q2 2026.
  • Vanguard Portfolio Management sold 319,532 Indivior Pharmaceuticals shares in Q2 2026, an estimated $11.6M.
  • Indivior Pharmaceuticals made up 0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #962 holding.
  • Vanguard Portfolio Management first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 315 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.